Wnt/frizzled signaling in Ewing sarcoma

被引:49
|
作者
Üren, A
Wolf, V
Sun, YF
Azari, A
Rubin, JS
Toretsky, JA
机构
[1] Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Washington, DC 20057 USA
[2] NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA
关键词
beta-catenin; Ewing sarcoma; frizzled; Wnt;
D O I
10.1002/pbc.20124
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The Ewing sarcoma family of tumors (ESFT) is a set of neuroectodermal malignancies that typically presents in the second decade and has a poor prognosis due to metastatic disease. Wnt signaling has a critical role in the normal development of multiple neuroectodermal tissues and also contributes to the neoplastic properties of tumor cells of neuroectodermal origin. Procedure. We surveyed the expression of Wnts and their receptors in nine ESFT cell lines by RT-PCR analysis. We also tested biological response of ESFT cell lines to exogenous Wnts in beta-catenin stabilization, actin stress fiber formation, and chemotaxis assays. Results. We detected Wnt-10b in all the lines, and most also expressed Wnt-5a, Wnt-11, and Wnt-13. Several Frizzleds (Fz) and the Wnt co-receptors, low density lipoprotein-receptor-like proteins 5 and 6 were also expressed. We observed a marked stimulation of the beta-catenin/canonical Wnt pathway in ESFT cells treated with Wnt-3a. Wnt-3a induced morphologic changes characterized by the formation of long cytoplasmic extensions in ESFT cells. We also observed chemotaxis of ESFT cells in response to Wnt-3a. Conclusions. These results provide evidence that components of Wnt/Fz pathway are expressed and an intact Wnt/Frizzled signaling pathway exists in ESFT cell lines. Activation of the Wnt pathway in ESFT suggests that Wnt modulates cell motility rather than cell proliferation. Hence, activation of this pathway may influence metastatic potential of ESFT. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 50 条
  • [1] Wnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors
    Pridgeon, Matthew G.
    Grohar, Patrick J.
    Steensma, Matthew R.
    Williams, Bart O.
    CURRENT OSTEOPOROSIS REPORTS, 2017, 15 (04) : 239 - 246
  • [2] Wnt/Frizzled signaling in angiogenesis
    Zerlin, Marielba
    Julius, Martin A.
    Kitajewski, Jan
    ANGIOGENESIS, 2008, 11 (01) : 63 - 69
  • [3] Wnt/Frizzled signaling in angiogenesis
    Marielba Zerlin
    Martin A. Julius
    Jan Kitajewski
    Angiogenesis, 2008, 11 : 63 - 69
  • [4] LGR5 is expressed by Ewing sarcoma and potentiates Wnt/beta-catenin signaling
    Scannell, Christopher A.
    Pedersen, Elisabeth A.
    Mosher, Jack T.
    Krook, Melanie Anne
    Nicholls, Lauren A.
    Wilky, Breelyn A.
    Loeb, David M.
    Lawlor, Elizabeth R.
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [5] Targeting Wnt-Frizzled signaling in cardiovascular diseases
    Pandey, Saumya
    Chandravati
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (10) : 6011 - 6018
  • [6] Wnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors
    Matthew G. Pridgeon
    Patrick J. Grohar
    Matthew R. Steensma
    Bart O. Williams
    Current Osteoporosis Reports, 2017, 15 : 239 - 246
  • [7] The Wnt/Frizzled GPCR Signaling Pathway
    Katanaev, V. L.
    BIOCHEMISTRY-MOSCOW, 2010, 75 (12) : 1428 - 1434
  • [8] The Wnt/Frizzled GPCR signaling pathway
    V. L. Katanaev
    Biochemistry (Moscow), 2010, 75 : 1428 - 1434
  • [9] WNT/Frizzled signaling in eye development and disease
    de Iongh, Robb U.
    Abud, Helen E.
    Hime, Gary R.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 2442 - 2464
  • [10] Wnt/frizzled signaling in hepatocellular carcinoma
    Lee, HC
    Kim, M
    Wands, JR
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 1901 - 1915